General Information
Revision date
2017-02-21
Product name
Abacavir and Lamivudine Tablets
CAS No.
188062-50-2
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Abacavir and lamivudine tablets are contraindicated in patients: • who have the HLA-B*5701 allele • with prior hypersensitivity reaction to abacavir or lamivudine. • with moderate or severe hepatic impairment
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
